Works by ROSENTHAL, NORM

Results: 16

Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.
Published in:
2016
By:
- Bilezikian, John P;
- Watts, Nelson B;
- Usiskin, Keith;
- Polidori, David;
- Fung, Albert;
- Sullivan, Daniel;
- Rosenthal, Norm
Publication type:
journal article
Sodium‐glucose co‐transporter‐2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta‐analysis.
Published in:
Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 252, doi. 10.1111/dom.14197
By:
- Li, Chao;
- Zhou, Zien;
- Neuen, Brendon L.;
- Yu, Jie;
- Huang, Yuli;
- Young, Tamara;
- Li, Jingwei;
- Li, Lin;
- Perkovic, Vlado;
- Jardine, Meg J.;
- Keay, Lisa;
- Markoulli, Maria;
- Rosenthal, Norm;
- Capuano, George;
- Yavin, Yshai;
- Neal, Bruce;
- Arnott, Clare
Publication type:
Article
Comment on "Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real‐world meta‐analysis of 4 observational databases (OBSERVE‐4D)"
Published in:
2019
By:
- Ryan, Patrick B.;
- Rosenthal, Norm
Publication type:
Letter to the Editor
Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: A retrospective cohort study.
Published in:
Diabetes, Obesity & Metabolism, 2018, v. 20, n. 3, p. 582, doi. 10.1111/dom.13115
By:
- Yuan, Zhong;
- Defalco, Frank J.;
- Ryan, Patrick B.;
- Schuemie, Martijn J.;
- Stang, Paul E.;
- Berlin, Jesse A.;
- Desai, Mehul;
- Rosenthal, Norm
Publication type:
Article
Comment on: Sodium-glucose co-transporter-2 inhibitors and risk of adverse renal outcomes among type 2 diabetes patients: A network and cumulative meta-analysis of randomized controlled trials.
Published in:
Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1823, doi. 10.1111/dom.13035
By:
- Canovatchel, William;
- Davidson, Jennifer;
- Rosenthal, Norm
Publication type:
Article
Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials.
Published in:
Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 926, doi. 10.1111/dom.12924
By:
- Neal, Bruce;
- Perkovic, Vlado;
- Mahaffey, Kenneth W.;
- Fulcher, Greg;
- Erondu, Ngozi;
- Desai, Mehul;
- Shaw, Wayne;
- Law, Gordon;
- Walton, Marc K.;
- Rosenthal, Norm;
- de Zeeuw, Dick;
- Matthews, David R.
Publication type:
Article
Renal safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus.
Published in:
Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 897, doi. 10.1111/dom.12876
By:
- Desai, Mehul;
- Yavin, Yshai;
- Balis, Dainius;
- Sun, Don;
- Xie, John;
- Canovatchel, William;
- Rosenthal, Norm
Publication type:
Article
Canagliflozin: a sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes mellitus.
Published in:
Annals of the New York Academy of Sciences, 2015, v. 1358, n. 1, p. 28, doi. 10.1111/nyas.12852
By:
- Rosenthal, Norm;
- Meininger, Gary;
- Ways, Kirk;
- Polidori, David;
- Desai, Mehul;
- Qiu, Rong;
- Alba, Maria;
- Vercruysse, Frank;
- Balis, Dainius;
- Shaw, Wayne;
- Edwards, Robert;
- Bull, Scott;
- Di Prospero, Nicholas;
- Sha, Sue;
- Rothenberg, Paul;
- Canovatchel, William;
- Demarest, Keith
Publication type:
Article
185-OR: Longitudinal Changes in KidneyIntelX and Association with Progressive Decline in Kidney Function in the CANVAS Trial.
Published in:
Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-185-OR
By:
- LAM, DAVID W.;
- NADKARNI, GIRISH N.;
- NEAL, BRUCE;
- MAHAFFEY, KENNETH W.;
- ROSENTHAL, NORM;
- HANSEN, MICHAEL K.;
- HEERSPINK, HIDDO L.;
- COCA, STEVEN
Publication type:
Article
139-LB: The Redox Balance Predicts Both Cardiovascular (CV) and Renal Outcomes in CANVAS.
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-139-LB
By:
- FERRANNINI, ELE;
- BALDI, SIMONA;
- SCOZZARO, TIZIANA;
- TESFAYE, FISSEHA;
- SHAW, WAYNE;
- ROSENTHAL, NORM;
- MAHAFFEY, KENNETH W.;
- NEAL, BRUCE;
- PERKOVIC, VLADO;
- HANSEN, MICHAEL K.
Publication type:
Article
27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease.
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-27-OR
By:
- LI, JINGWEI;
- JARDINE, MEG J.;
- NEAL, BRUCE;
- HEERSPINK, HIDDO L.;
- CANNON, CHRISTOPHER;
- AGARWAL, RAJIV;
- BAKRIS, GEORGE;
- CHARYTAN, DAVID M.;
- ZEEUW, DICK DE;
- EDWARDS, ROBERT;
- GREENE, TOM;
- LEVIN, ADEERA;
- POLLOCK, CAROL A.;
- ROSENTHAL, NORM;
- WHEELER, DAVID C.;
- ZHANG, HONG;
- ZINMAN, BERNARD;
- PERKOVIC, VLADO;
- MAHAFFEY, KENNETH W.;
- ARNOTT, CLARE
Publication type:
Article
26-OR: Acute Declines in EGFR during Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE.
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-26-OR
By:
- OSHIMA, MEGUMI;
- JARDINE, MEG J.;
- AGARWAL, RAJIV;
- BAKRIS, GEORGE;
- CANNON, CHRISTOPHER;
- CHARYTAN, DAVID M.;
- ZEEUW, DICK DE;
- EDWARDS, ROBERT;
- GREENE, TOM;
- LEVIN, ADEERA;
- MAHAFFEY, KENNETH W.;
- NEAL, BRUCE;
- POLLOCK, CAROL A.;
- ROSENTHAL, NORM;
- WHEELER, DAVID C.;
- ZHANG, HONG;
- ZINMAN, BERNARD;
- PERKOVIC, VLADO;
- HEERSPINK, HIDDO L.
Publication type:
Article
1123-P: Stress Cardiac Biomarkers and Adverse Cardiac Outcomes in the CANagliflozin CardioVascular Assessment Study (CANVAS).
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1123-P
By:
- SATTAR, NAVEED;
- XU, JIALIN;
- BUTLER, JAVED;
- MAHAFFEY, KENNETH W.;
- SHAW, WAYNE;
- ROSENTHAL, NORM;
- GUTSTEIN, DAVID E.;
- HANSEN, MICHAEL K.;
- JANUZZI JR., JAMES
Publication type:
Article
1120-P: Association between the Inflammatory Marker GDF-15 and Kidney Disease Progression: Results from the CANVAS Trial.
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1120-P
By:
- LI, JINGWEI;
- SEN, TAHA;
- NEAL, BRUCE;
- NEUEN, BRENDON L.;
- PERKOVIC, VLADO;
- ZEEUW, DICK DE;
- MAHAFFEY, KENNETH W.;
- YAVIN, YSHAI;
- ROSENTHAL, NORM;
- HANSEN, MICHAEL K.;
- HEERSPINK, HIDDO L.
Publication type:
Article
1098-P: Biomarkers of Tubular Injury and Effects of Canagliflozin in the CANVAS Trial.
Published in:
Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1098-P
By:
- SEN, TAHA;
- LI, JINGWEI;
- NEAL, BRUCE;
- NEUEN, BRENDON L.;
- JARDINE, MEG J.;
- IX, JOACHIM;
- SHLIPAK, MICHAEL G.;
- PERKOVIC, VLADO;
- YAVIN, YSHAI;
- ROSENTHAL, NORM;
- HANSEN, MICHAEL K.;
- HEERSPINK, HIDDO L.
Publication type:
Article
1546-P: Acute Pancreatitis (AP) with Canagliflozin (CANA) vs. Other Antihyperglycemic Agents (AHAs): An Observational Study.
Published in:
Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1546-P
By:
- YUAN, ZHONG;
- DEFALCO, FRANK;
- WANG, LU;
- HESTER, LAURA L.;
- SWERDEL, JOEL N.;
- FREEDMAN, AMY;
- RYAN, PATRICK;
- SCHUEMIE, MARTIJN;
- QIU, ROSE;
- YEE, JACQUELINE;
- MEININGER, GARY;
- BERLIN, JESSE A.;
- ROSENTHAL, NORM
Publication type:
Article